Mark D. Romer

Hematology
2350 Miami Valley Dr
Centerville, OH 45459

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL.

Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL.

Journal: Blood
Published: January 18, 2024
Showing 1-1 of 1

Last Updated: 09/26/2026